Armistice Capital’s Azora Therapeutics AZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-102,178
Closed -$562K – 265
2025
Q4
$562K Buy
+102,178
New +$827K 0.01% 208
2024
Q1
– Sell
-6,360
Closed -$296K – 338
2023
Q4
$296K Buy
+6,360
New +$349K ﹤0.01% 220
2022
Q2
– Sell
-2,908
Closed -$3.65M – 177
2022
Q1
$3.65M Buy
+2,908
New +$3.98M 0.07% 87

Other funds holding AZR

Armistice Capital's AZR Position: Q1 2026 in Review

Armistice Capital sold out of Azora Therapeutics (AZR) in Q1 2026, closing a stake of 102,178 shares — an estimated $562K sold.

Armistice Capital first reported a position in AZR in Q1 2022 and held it in 3 quarters. The position peaked at $3.65M in Q1 2022. 15 funds tracked by Wall St. Rank hold AZR as of Q1 2026.

  • Armistice Capital reported no remaining Azora Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Armistice Capital sold 102,178 Azora Therapeutics shares in Q1 2026, an estimated $562K.
  • Armistice Capital first reported a position in Azora Therapeutics in Q1 2022 and held it in 3 quarters.
  • Armistice Capital's Azora Therapeutics position peaked at $3.65M in Q1 2022.
  • 15 funds tracked by Wall St. Rank held Azora Therapeutics as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.